Magnephy focuses on 3D imaging of the kidneys and develops new protocols in optical tissue pathology, with the aim of improving and levelling the differences in the assessment of kidney diseases by hospitals. Magnephy also helps pharmaceutical companies with molecular and morphological quantitative kidney imaging to support drug testing. The company was founded in 2023.
Its founders include MedTechLabs researchers Hans Blom, Robin Ebbestad and David Unnersjö-Jess.
We use cookies to improve your user experience and to collect information about your visit. You can read more about our cookies and change your settings here. Read more
Cookie preferences
Cookies save information about how you use the website, data that can be reused. Read more
These cookies are necessary for our website to function and therefore cannot be turned off. They are used, for example, when you set personal preferences, log in or fill out a form. You can set your browser to block or warn you about these cookies, but some parts of the website will not work then.
These cookies make it possible to provide improved functionality and customization on our website. If you do not allow these cookies, some functions may not work correctly.
These cookies allow us to count the number of visits and traffic sources so that we can measure and improve our website. The information these cookies collect is completely anonymous. If you do not allow these cookies, we will not know when you have visited our website.
